Stocks›Healthcare›IQV

IQV

IQVIA HOLDINGS INC.

NYSEResearch view

$270.37−1.69%

Sep 25 close · 1D EOD · Databento

HealthcareServices-Commercial Physical & Biological ResearchLarge-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 28, 2025 and Oct 31, 2024, before the open.

Last report

Jul 28, 2026+13.94%

before the open

Last 4, next close

median 10.13% either way

up 3 of 4

Every report since 2022 →

DateEventSourceNext close

Jul 28Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗+13.94%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

Big days · last year

Daily closes · Databento EOD

24 big days: a close more than 3.61% from the one before, three times IQV’s median day (1.20%). On 20 of 24, its largest peers moved the same way at least half as far. We show what we hold, never a cause.

Shaded: since our stories began, May 26, 2026

24Aug 19, 2026
Aug 19, 2026Nothing in our recordNo IQV story, brief or results filing in our record that dayGroup +3.6% moved the same way
+3.6% moved the same wayINCY +4.0 · CRL +3.9 · ICLR +3.3 · MEDP +3.0
+3.85%
23Jul 30, 2026
Jul 30, 2026Nothing in our recordNo IQV story, brief or results filing in our record that dayGroup −2.2% moved the same way
−2.2% moved the same wayICLR −7.1 · INCY −3.2 · MEDP −1.1 · CRL −0.1
−3.95%
22Jul 28, 2026
Jul 28, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group +7.0% moved the same way
+7.0% moved the same wayINCY +9.3 · CRL +7.2 · ICLR +6.8 · MEDP −3.1
+13.94%
21Jul 23, 2026
Jul 23, 2026Nothing in our recordNo IQV story, brief or results filing in our record that dayGroup +3.3% moved the same way
+3.3% moved the same wayMEDP +14.7 · CRL +4.8 · ICLR +1.8 · INCY +0.8
+4.43%
20Jul 1, 2026
Jul 1, 2026Nothing in our recordNo IQV story, brief or results filing in our record that dayGroup +0.9% did not move with it
+0.9% did not move with itMEDP +2.6 · CRL +1.0 · ICLR +0.8 · INCY +0.4
+5.17%
19Jun 24, 2026
Jun 24, 2026Nothing in our recordNo IQV story, brief or results filing in our record that dayGroup +8.3% moved the same way
+8.3% moved the same wayICLR +10.9 · CRL +8.3 · MEDP +8.3 · INCY +3.9
+8.37%
18Jun 17, 2026
Jun 17, 2026Nothing in our recordNo IQV story, brief or results filing in our record that dayGroup −0.9% did not move with it
−0.9% did not move with itCRL −1.3 · MEDP −1.0 · INCY −0.8 · ICLR −0.2
−4.74%
17May 28, 2026
May 28, 2026Nothing in our recordNo IQV story, brief or results filing in our record that dayGroup +7.5% moved the same way
+7.5% moved the same wayICLR +15.5 · CRL +10.2 · MEDP +4.7 · INCY +0.2
+9.34%
16May 5, 2026
May 5, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group +5.4% moved the same way
+5.4% moved the same wayICLR +8.3 · CRL +7.6 · MEDP +3.2 · INCY +0.3
+9.62%
15Apr 23, 2026
Apr 23, 2026Before our storiesGroup −8.6% moved the same way
−8.6% moved the same wayMEDP −22.6 · CRL −9.2 · ICLR −7.9 · INCY −1.3
−8.29%
14Mar 12, 2026
Mar 12, 2026Before our storiesGroup −7.3% moved the same way
−7.3% moved the same wayCRL −9.6 · ICLR −7.5 · MEDP −7.1 · INCY −2.8
−5.04%
13Mar 10, 2026
Mar 10, 2026Before our storiesGroup −2.8% moved the same way
−2.8% moved the same wayCRL −5.4 · ICLR −3.1 · MEDP −2.5 · INCY −1.1
−4.27%
12Feb 27, 2026
Feb 27, 2026Before our storiesGroup +1.5% did not move with it
+1.5% did not move with itICLR +1.9 · CRL +1.7 · INCY +1.2 · MEDP +1.0
+4.79%
11Feb 26, 2026
Feb 26, 2026Before our storiesGroup +3.4% moved the same way
+3.4% moved the same wayICLR +5.1 · CRL +4.7 · MEDP +2.1 · INCY +0.1
+5.39%
10Feb 18, 2026
Feb 18, 2026Before our storiesGroup +3.0% moved the same way
+3.0% moved the same wayICLR +8.9 · MEDP +4.2 · INCY +1.8 · CRL −0.3
+4.03%
9Feb 12, 2026
Feb 12, 2026Before our storiesGroup −3.1% moved the same way
−3.1% moved the same wayICLR −39.9 · CRL −4.4 · INCY +1.9 · MEDP −1.9
−4.70%
8Feb 10, 2026
Feb 10, 2026Before our storiesGroup −7.4% moved the same way
−7.4% moved the same wayMEDP −15.9 · INCY −8.2 · ICLR −6.5 · CRL −2.4
−5.30%
7Feb 6, 2026
Feb 6, 2026Before our storiesGroup +3.3% moved the same way
+3.3% moved the same wayINCY +5.5 · ICLR +3.6 · CRL +3.0 · MEDP +0.1
+3.61%
6Feb 5, 2026
Feb 5, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group −6.3% moved the same way
−6.3% moved the same wayICLR −10.9 · CRL −8.9 · MEDP −3.6 · INCY +0.2
−10.65%
5Feb 3, 2026
Feb 3, 2026Before our storiesGroup −4.4% did not move with it
−4.4% did not move with itICLR −6.0 · CRL −5.5 · MEDP −3.3 · INCY −1.7
−11.88%
4Jan 5, 2026
Jan 5, 2026Before our storiesGroup +2.8% moved the same way
+2.8% moved the same wayICLR +4.7 · CRL +2.9 · MEDP +2.8 · INCY +0.4
+4.09%
3Oct 20, 2025
Oct 20, 2025Before our storiesGroup +2.5% moved the same way
+2.5% moved the same wayCRL +3.1 · MEDP +3.1 · ICLR +1.8 · INCY −1.6
+3.67%
2Oct 1, 2025
Oct 1, 2025Before our storiesGroup +7.4% moved the same way
+7.4% moved the same wayICLR +9.9 · CRL +9.0 · MEDP +5.8 · INCY +2.2
+7.29%
1Sep 30, 2025
Sep 30, 2025Before our storiesGroup +4.6% moved the same way
+4.6% moved the same wayICLR +7.1 · CRL +6.4 · MEDP +2.7 · INCY +1.1
+5.10%

A story on the same day is not a cause, and a group move is not proof either. Group: INCY, MEDP, CRL, ICLR, the largest companies in IQV’s SEC industry; “the same way” means the same direction and at least half as far. Prior-session closes only; not a call, not advice.

The numbers · FY2025, filed

SEC EDGAR

Market cap$44.5B

Revenue$16.3B+5.90%

Net income$1.4B

EPS, diluted$7.84+4.70%

Operating margin13.4%

Return on equity20.5%

Debt / equity2.37

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$44.5B

Enterprise Value$58.2B

Income$1.4B

Sales$16.3B

Book/sh$39.72

Cash/sh$11.86

Dividend TTM—

Payout42%

Employees—

IPO—

Quick Ratio—

Current Ratio0.75

Debt/Eq2.37

EPS (ttm)$7.84

EPS this Y4.7%

EPS past 3/5Y11.1%

Sales past 3/5Y4.2%

EPS Y/Y TTM4.7%

Sales Y/Y TTM5.9%

Shs Outstand166.90M

ROA4.5%

ROE20.5%

ROIC9.0%

Gross Margin—

Oper. Margin13.4%

Profit Margin8.3%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$13.9B

FY21

$14.4B

FY22

$15.0B

FY23

$15.4B

FY24

$16.3B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$13.9B	$14.4B	$15.0B	$15.4B	$16.3B
Gross Profit	—	—	—	—	—
Operating Income	$1.4B	$1.8B	$2.0B	$2.2B	$2.2B
Net Income	$966.0M	$1.1B	$1.4B	$1.4B	$1.4B
Diluted EPS	$4.95	$5.72	$7.29	$7.49	$7.84
Operating Cash Flow	$2.9B	$2.3B	$2.1B	$2.7B	$2.7B
Free Cash Flow	—	—	—	—	—

Same industry

In the screener →

INCY$25.1B MEDP$17.3B CRL$14.0B ICLR$13.2B ABSI$1.7B OABI$670M NRC$433M MXCT$121M

Build basket with IQV Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.